These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9566104)

  • 61. Comparison of intramuscular gold and sulphasalazine in the treatment of early rheumatoid arthritis. A one year prospective study.
    Peltomaa R; Paimela L; Helve T; Leirisalo-Repo M
    Scand J Rheumatol; 1995; 24(6):330-5. PubMed ID: 8610215
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Superficial Tissue Necrosis Related to Methotrexate Injection in a Patient With Rheumatoid Arthritis.
    Estrada Alarcon PV; García-Díaz S; Oña M; Corominas H
    J Clin Rheumatol; 2015 Oct; 21(7):370. PubMed ID: 26398466
    [No Abstract]   [Full Text] [Related]  

  • 63. [Treatment of chronic polyarthritis with methotrexate 1994--a review].
    Rau R
    Z Rheumatol; 1994; 53(4):199-229. PubMed ID: 7975933
    [No Abstract]   [Full Text] [Related]  

  • 64. Methotrexate-induced accelerated nodulosis in a patient with rheumatoid arthritis and scleroderma.
    Motegi S; Ishikawa O
    Acta Derm Venereol; 2014 May; 94(3):357-8. PubMed ID: 24158350
    [No Abstract]   [Full Text] [Related]  

  • 65. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial.
    Haagsma CJ; van Riel PL; de Jong AJ; van de Putte LB
    Br J Rheumatol; 1997 Oct; 36(10):1082-8. PubMed ID: 9374925
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Safe prescribing of methotrexate for rheumatoid arthritis.
    Kirkham BW
    Med J Aust; 1995 Sep; 163(5):278. PubMed ID: 7565224
    [No Abstract]   [Full Text] [Related]  

  • 67. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
    Singer O; Gibofsky A
    Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis.
    Cummins L; Katikireddi VS; Shankaranarayana S; Su KY; Duggan E; Videm V; Pahau H; Thomas R
    Intern Med J; 2015 Dec; 45(12):1266-73. PubMed ID: 26384029
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The ability of disease modifying antirheumatic drugs to induce and maintain improvement in patients with rheumatoid arthritis. epidemiology of DMARDs treatment in Japan.
    Nagashima M; Shu G; Yamamoto K; Yamahatsu S; Yoshino S
    Clin Exp Rheumatol; 2005; 23(1):27-35. PubMed ID: 15789884
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Sulphasalazine in patients with rheumatoid arthritis in China: a cross-sectional study].
    Liu T; Wang XR; An Y; Zhou YS; Zhang XY; Duan TJ; Zhu JX; Li XF; Wang LZ; Wang CH; Wang YF; Yang R; Wang GC; Lu X; Zhu P; Chen LN; Jin HT; Liu XY; Sun L; Chen HY; Cui LF; Shu R; Liu BL; Zhang ZL; Li GT; Li ZB; Yang J; Li JF; Jia B; Zhang FX; Tao JM; Han SL; Lin JY; Wei MQ; Liu XM; Ke D; Hu SX; Ye C; Yang XY; Li H; Huang CB; Gao M; Lai P; Li XF; Song LJ; Wang Y; Wang XY; Mu R; Su Y; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):188-94. PubMed ID: 22516985
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group.
    Möttönen T; Hannonen P; Leirisalo-Repo M; Nissilä M; Kautiainen H; Korpela M; Laasonen L; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Ilva K; Yli-Kerttula U; Puolakka K; Järvinen P; Hakola M; Piirainen H; Ahonen J; Pälvimäki I; Forsberg S; Koota K; Friman C
    Lancet; 1999 May; 353(9164):1568-73. PubMed ID: 10334255
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.
    Choy EH; Scott DL; Kingsley GH; Williams P; Wojtulewski J; Papasavvas G; Henderson E; Macfarlane D; Erhardt C; Young A; Plant MJ; Panayi GS
    Clin Exp Rheumatol; 2002; 20(3):351-8. PubMed ID: 12102471
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Grade 3 lymphomatoid granulomatosis in a patient receiving methotrexate therapy for rheumatoid arthritis.
    Oiwa H; Mihara K; Kan T; Tanaka M; Shindo H; Kumagai K; Sugiyama E
    Intern Med; 2014; 53(16):1873-5. PubMed ID: 25130128
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Complications with low dose methotrexate in rheumatoid arthritis.
    Kalke S; Balakrishnan C; Mittal G; Mangat G; Joshi VR
    J Assoc Physicians India; 1997 Nov; 45(11):903-4. PubMed ID: 11229210
    [No Abstract]   [Full Text] [Related]  

  • 75. [Methotrexate: mainstay of rheumatoid arthritis treatment].
    Jacobs JW; Bijlsma JW
    Ned Tijdschr Geneeskd; 2009; 153():A879. PubMed ID: 19785862
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Methotrexate therapy in rheumatologic diseases--an update].
    Cauza E; Dunky A
    Wien Med Wochenschr; 2003; 153(13-14):291-4. PubMed ID: 12924103
    [TBL] [Abstract][Full Text] [Related]  

  • 77. What dose of folic acid to use with methotrexate in rheumatoid arthritis?
    Bramley D
    Drug Ther Bull; 2021 Jul; 59(7):103-106. PubMed ID: 34162667
    [No Abstract]   [Full Text] [Related]  

  • 78. Accelerated nodulosis immediately after initiating weekly low dose methotrexate for rheumatoid arthritis.
    Jun JB; Koh HK; Bae SC; Yoo DH; Kim SY
    Clin Exp Rheumatol; 1999; 17(1):127. PubMed ID: 10084052
    [No Abstract]   [Full Text] [Related]  

  • 79. [Therapy of rheumatoid arthritis with etanercept].
    Lamprecht P; Nitschmann S
    Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
    [No Abstract]   [Full Text] [Related]  

  • 80. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
    Hørslev-Petersen K; Hetland ML; Junker P; Pødenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Johansen JS; Østergaard M; Stengaard-Pedersen K;
    Ann Rheum Dis; 2014 Apr; 73(4):654-61. PubMed ID: 23434570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.